Omega Protein Corporation (NYSE:OME) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure
On January 23, 2017, Omega Protein Corporation (the Company)
issued a press release announcing the initiation of a quarterly
dividend program. This press release is filed as Exhibit 99.1 to
this Current Report on Form 8-K and is incorporated herein by
reference.
In accordance with General Instruction B.2 of Form 8-K, the
foregoing information, including Exhibit 99.1, shall not be
deemed filed for the purposes of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of
that section, nor shall such information and Exhibit be deemed
incorporated by reference in any filing under the Securities Act
of 1933 or the Exchange Act, except as shall be expressly set
forth by specific reference in such a filing.
Item 8.01. Other Events
The Companys Board of Directors hasestablished a dividend program
under which the Company intends to pay a regular quarterly cash
dividend to its shareholders. The initial quarterly cash dividend
of $0.05 per share is payable on March 15, 2017 to shareholders
of record as of the close of business on February 22, 2017.
Subsequent dividend declarations and the establishment of record
and payment dates for such future dividend payments, if any, are
subject to the Board of Directors continuing determination that
the dividend policy is in the best interests of the Companys
shareholders as well as compliance with applicable legal
requirements. The dividend program may be suspended or cancelled
at the discretion of the Board of Directors at any time.
Item 9.01 Financial Statements, Pro
Forma Financial Information and
Exhibits
|
(a) |
Financial Statements of business acquired. |
None.
|
(b) |
Pro Forma Financial Information. |
None.
|
(c) |
Shell Company Transactions. |
None.
|
(d) |
Exhibits. |
|
99.1 |
Text of Press Release dated January 23, 2017 titled |
About Omega Protein Corporation (NYSE:OME)
Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products across the world. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists primarily of two subsidiaries: Omega Protein, Inc. (Omega Protein) and Omega Shipyard, Inc. (Omega Shipyard). Omega Protein operates approximately three menhaden processing plants in the states of Louisiana, Mississippi and Virginia. The human nutrition segment does business under the name Bioriginal, which includes all of the human nutrition businesses. Bioriginal has over three primary product lines: plant and marine based specialty oils, protein products and other nutraceutical ingredients. Bioriginal consists of approximately four subsidiaries: Bioriginal Food & Science Corp. (Bioriginal Food & Science), Wisconsin Specialty Protein, L.L.C. (WSP), Cyvex Nutrition, Inc. (Cyvex) and InCon Processing, L.L.C. (InCon). Omega Protein Corporation (NYSE:OME) Recent Trading Information
Omega Protein Corporation (NYSE:OME) closed its last trading session down -0.20 at 25.15 with 103,244 shares trading hands.
